Cancer Check Labs
Cancer Check Labs offers a breakthrough Multi-Cancer Early Detection (MCED) blood test that identifies solid tumor cancers as early as Stage 0. Their unique selling proposition is the provision of a board-certified pathology report with every test result, reviewed by a qualified medical doctor, ensuring expert interpretation. The test detects Circulating Tumor Cells (CTCs) through a simple blood draw, utilizing established staining protocols like Hematoxylin and Eosin (H&E) and Immunohistochemistry (IHC). Cancer Check Labs focuses on proven, reliable diagnostic methods, avoiding less established techniques such as signaling, ctDNA analysis, or AI. The company partners with medical doctors, functional health practices, wellness centers, med spas, and employers to offer this innovative screening. The test is available in the United States for $1,995, with plans for international availability.
Cancer Check Labs
Cancer Check Labs offers a breakthrough Multi-Cancer Early Detection (MCED) blood test that identifies solid tumor cancers as early as Stage 0. Their unique selling proposition is the provision of a board-certified pathology report with every test result, reviewed by a qualified medical doctor, ensuring expert interpretation. The test detects Circulating Tumor Cells (CTCs) through a simple blood draw, utilizing established staining protocols like Hematoxylin and Eosin (H&E) and Immunohistochemistry (IHC). Cancer Check Labs focuses on proven, reliable diagnostic methods, avoiding less established techniques such as signaling, ctDNA analysis, or AI. The company partners with medical doctors, functional health practices, wellness centers, med spas, and employers to offer this innovative screening. The test is available in the United States for $1,995, with plans for international availability.